Donkey-Hide Gelatin Seeks Drug Application In Korea
This article was originally published in PharmAsia News
Shandong Dong-E E-Jiao Group has applied for Korea FDA drug registration for its donkey-hide gelatin (ejiao) used in traditional Chinese tonic products. KFDA's approval of the three formulations in block, cream, and granules would end the history of the gelatin as mere raw material imported for making drugs. Reports say that a donkey-hide gelatin cosmetic product developed by a Korean university is now undergoing clinical trials. China's donkey-hide gelatin export is growing at a rate of more than 30 percent annually. The product has successfully entered European and American markets. (Click here for more)
You may also be interested in...
The UK regulator is expecting a rise in amendments and deviations to ongoing clinical investigations of medical devices due to the COVID-19 pandemic and has issued advice on how companies should manage these.
Mylan and Pfizer’s Upjohn, already facing a delay to their proposed merger, may have to overcome regulatory barriers to get the deal over the line.
National export restrictions on medicines have been slammed by the international off-patent pharmaceutical industry as being “counter-productive” during the coronavirus crisis. The IGBA is instead urging international co-operation and transparency, pointing to a positive example of supply-chain connectivity in the Asia-Pacific region.